These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 19093333)

  • 1. Myelodysplastic syndromes: disease overview and therapy options.
    Coutré S
    Manag Care; 2008 Jul; 17(7 Suppl 6):3-8. PubMed ID: 19093333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myelodysplastic syndromes: a practical approach to diagnosis and treatment.
    Barzi A; Sekeres MA
    Cleve Clin J Med; 2010 Jan; 77(1):37-44. PubMed ID: 20048028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An assessment of erythroid response to epoetin alpha as a single agent versus in combination with granulocyte- or granulocyte-macrophage-colony-stimulating factor in myelodysplastic syndromes using a meta-analysis approach.
    Mundle S; Lefebvre P; Vekeman F; Duh MS; Rastogi R; Moyo V
    Cancer; 2009 Feb; 115(4):706-15. PubMed ID: 19152429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supportive care and use of hematopoietic growth factors in myelodysplastic syndromes.
    Hellström-Lindberg E; Malcovati L
    Semin Hematol; 2008 Jan; 45(1):14-22. PubMed ID: 18179965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managing patients with low-risk MDS.
    Sekeres M; Cosgrove D; Falco A
    Clin Adv Hematol Oncol; 2006 Jul; 4(7 Suppl 16):1-10; quiz 11-2. PubMed ID: 17139240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myelodysplastic syndromes clinical practice guidelines in oncology.
    Greenberg PL; Baer MR; Bennett JM; Bloomfield CD; De Castro CM; Deeg HJ; Devetten MP; Emanuel PD; Erba HP; Estey E; Foran J; Gore SD; Millenson M; Navarro WH; Nimer SD; O'Donnell MR; Saba HI; Spiers K; Stone RM; Tallman MS
    J Natl Compr Canc Netw; 2006 Jan; 4(1):58-77. PubMed ID: 16403405
    [No Abstract]   [Full Text] [Related]  

  • 7. [Myelodysplastic syndromes].
    Paladini G; Pecorari P; De Sabbata G; Sammartini C
    Recenti Prog Med; 2004 Feb; 95(2):108-19. PubMed ID: 15072397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myelodysplastic syndromes: a review for nurses.
    Cain J; Hood-Barnes J; Spangler J
    Oncol Nurs Forum; 1991; 18(1):113-7. PubMed ID: 2003103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidelines for the diagnosis and therapy of adult myelodysplastic syndromes.
    Bowen D; Culligan D; Jowitt S; Kelsey S; Mufti G; Oscier D; Parker J;
    Br J Haematol; 2003 Jan; 120(2):187-200. PubMed ID: 12542475
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute myeloid leukaemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
    Ferretti G; Papaldo P
    Breast Cancer Res Treat; 2008 May; 109(1):187-8. PubMed ID: 17616805
    [No Abstract]   [Full Text] [Related]  

  • 11. Prognosis and therapy of secondary myelodysplastic syndromes.
    Estey EH
    Haematologica; 1998 Jun; 83(6):543-9. PubMed ID: 9676028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myelodysplastic Syndromes, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.
    Greenberg PL; Stone RM; Al-Kali A; Barta SK; Bejar R; Bennett JM; Carraway H; De Castro CM; Deeg HJ; DeZern AE; Fathi AT; Frankfurt O; Gaensler K; Garcia-Manero G; Griffiths EA; Head D; Horsfall R; Johnson RA; Juckett M; Klimek VM; Komrokji R; Kujawski LA; Maness LJ; O'Donnell MR; Pollyea DA; Shami PJ; Stein BL; Walker AR; Westervelt P; Zeidan A; Shead DA; Smith C
    J Natl Compr Canc Netw; 2017 Jan; 15(1):60-87. PubMed ID: 28040720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of myelodysplastic syndromes aside from clinical studies].
    Lengfelder E; Hehlmann R
    Dtsch Med Wochenschr; 1995 Nov; 120(44):1527. PubMed ID: 7588024
    [No Abstract]   [Full Text] [Related]  

  • 14. [Anemia in the elderly patient. Is it a myelodysplastic syndrome?].
    MMW Fortschr Med; 2012 Feb; 154(3):26. PubMed ID: 22458163
    [No Abstract]   [Full Text] [Related]  

  • 15. Rapid disease progression in two cases of myelodysplastic syndrome (MDS) following short therapy with G-CSF.
    Zomas A; Fisfis M; Stefanoudaki-Sofianatou K
    Haematologica; 1997; 82(2):253-4. PubMed ID: 9175335
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of transfusion on survival in patients with myelodysplastic syndromes: Current knowledge, new insights and transfusion clinical practice.
    Kaphan E; Laurin D; Lafeuillade B; Drillat P; Park S
    Blood Rev; 2020 May; 41():100649. PubMed ID: 31918886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of myelodysplastic syndromes in adults: guidelines from the Belgian Haematological Society.
    Meers S; Breems D; Bries G; Delforge M; Graux C; Ravoet C; Selleslag D; Noens L;
    Acta Clin Belg; 2013; 68(4):253-62. PubMed ID: 24455794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myelodysplastic syndromes: aspects of current medical care and economic considerations in Germany.
    Gattermann N; Hofmann WK; Meessen A; Schmitz S; Tsamaloukas A; Vollmer T; Wedding U; Plesnila-Frank C; Schramm W; Berger K
    Onkologie; 2008 Sep; 31(8-9):477-84. PubMed ID: 18787357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in the management of low- to intermediate-risk myelodysplastic syndrome: Integrating the National Comprehensive Cancer Network guidelines.
    Kurtin SE
    Clin J Oncol Nurs; 2006 Apr; 10(2):197-208. PubMed ID: 16708703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging therapeutic and supportive care approaches for the myelodisplastic syndromes.
    Mufti GJ
    Rev Clin Exp Hematol; 2004 Dec; 8(2):E4. PubMed ID: 16027102
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.